CGCheryl Y. Gregory-Evans

Cheryl Y. Gregory-Evans

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cheryl Y. Gregory-Evans has a total of 114 co-authors. Here are the top co-authors by number of shared publications:

  • Kevin Gregory-Evans

    University of British Columbia, Department of Ophthalmology & Visual Sciences, Vancouver, BC, Canada

    13 shared publications
  • Kevin Gregory-Evans

    Department of Ophthalmology and Visual Sciences, University of British Columbia, Canada

    7 shared publications
  • Xia Wang

    Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver BC V5Z 3N9, Canada

    5 shared publications
  • Xianghong Shan

    Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver BC V5Z 3N9, Canada

    5 shared publications
  • Ishaq A. Viringipurampeer

    Department of Ophthalmology and Visual Sciences Eye, Care Centre University of British Columbia Vancouver Canada

    3 shared publications
  • Anat Yanai

    Department of Ophthalmology and Visual Sciences Eye, Care Centre University of British Columbia Vancouver Canada

    2 shared publications

Latest Publications

  • Open Access

    Two novel genetic associations with sector retinitis pigmentosa: USH2A and PRPF31

    by Shanil R. Dhanji, Kirk A. J. Stephenson, Cheryl Y. Gregory-Evans, Kevin Gregory-Evans

    Sector retinitis pigmentosa (RP) is an attenuated phenotype in comparison to classic pan-retinal disease. The inferior retina is most often affected, though other quadrants may become involved with time, particularly with more damaging genetic variants. Sector RP has been described in association with several known genotypes, most commonly RHO. Case series of patients with a sector RP phenotype (and any affected family) and review of the literature. We describe two new genetic associations of sector RP: USH2A and PRPF31. Proband 1 had sector RP due to homozygous USH2A:c.13274C>T' variants while proband 2 had sector RP due to a heterozygous PRPF31:c.351dup variant. There was significant intrafamilial variability in each pedigree. Though both variants are previously reported, the phenotype in those reports was not consistent with sector RP. The current USH2A pedigree is the first reported with the c.13274C>T' variant homozygously, expressing a restricted, predominantly perivascular, sectoral RP. Non-syndromic USH2 genes have not previously been associated with sector RP. In the PRPF31 pedigree (c.351dup), the proband has restricted/sectoral disease but her daughter has classic pan-retinal RP. The cause of the attenuated phenotype and intrafamilial variability is unknown but could depend on several factors including occult modifier genes and environmental influences (e.g. light exposure to the inferior retina).


  • Genotypic and phenotypic landscape of novel RPGR variants in patients from Western Canada

    by Cheryl Y. Gregory-Evans, Maheshver Shunmugam, Boaz Li, Kevin Gregory-Evans


  • Open Access

    Expanding the Genotypic Landscape of Congenital Stationary Night Blindness in an Ethnically Diverse Canadian Population

    by Jennifer Ling, Mustansir Pindwarawala, Cheryl Y. Gregory-Evans, Mathew Kirby, Kevin Gregory-Evans

    Congenital stationary night blindness (CSNB) is a rare and typically nonprogressive group of genetically heterogeneous disorders resulting in impaired night vision and high myopia with varying levels of visual impairment. Despite being a rare disease with a prevalence of 1:294,000, variants in 22 genes have been associated with specific CSNB phenotypes. Approximately, 13% of cases remain without a genetic diagnosis, highlighting the importance of ongoing genetic studies. Clinical and diagnostic information was collected retrospectively from patients who were diagnosed with CSNB. Patients underwent full ophthalmic examination, including best‐corrected visual acuity (BCVA), direct and indirect ophthalmoscopy, retinal imaging, and full field electroretinography. All patients underwent panel‐based genetic testing for complete and incomplete CSNB genes to identify DNA variants from buccal swab samples. In the 49‐patient cohort (from 38 families) with complete and incomplete CSNB, a conclusive molecular diagnosis was found in 30 patients (61.2%) with a known disease‐causing variant in a CSNB gene. We identified 21 novel variants in five genes ( CACNA1F , NYX , TRPM1 , GPR 197, and GRK1 ), and in one patient, the genetic defect remains to be identified. After in silico modeling and clinical correlation, 18 of these novel variants were considered pathogenic or likely pathogenic. When compared with ethnicity, CSNB was overwhelmingly present in White people, and we did not find any Indigenous people with CSNB. Prevalence of CSNB in the Mennonite community was estimated to be 1:967, approximately 300 times the expected prevalence. Establishing a molecular diagnosis of CSNB is critical because it enables many actionable outcomes including further family testing, genetic counseling, and access to future clinical trials.

  • The effect of oral belzutifan on retinal hemangioblastomas in von Hippel–Lindau syndrome

    by Kirk A.J. Stephenson, Jennifer Y.M. Ling, Olubayo U. Kolawole, Melanie O’LOughlin, Lica Chui, Cheryl Y. Gregory-Evans, Kevin Gregory-Evans, Maryam Soleimani, Patrick E. Ma

  • Open Access

    Mutation of beta-tubulin 4B gene ( TUBB4B) causes autosomal dominant retinitis pigmentosa with sensorineural hearing loss in a multigenerational family

    by Cheryl Y. Gregory-Evans, Aaron W. Joe, Kevin Gregory-Evans

    Purpose: Members of a multigenerational Canadian family presented to an inherited retinal degeneration (IRD) clinic with retinitis pigmentosa (RP) and sensorineural hearing loss, reminiscent of an Usher syndrome phenotype. Biallelic disease-causing variants in the known Usher syndrome genes were not identified. Therefore, we enrolled further family members in this study and examined whether other IRD gene variants could explain the phenotype in the family. Methods: Family members underwent a comprehensive ophthalmic examination, including best-corrected visual acuity, direct and indirect ophthalmoscopy, fundus photography, visual field testing, spectral-domain optical coherence tomography, audiological examination, and genetic testing. Some patients also had autofluorescence imaging. Loss-of-function testing was initiated by antisense morpholino knockdown of tubb4b in zebrafish. Results: Multimodal clinical testing in affected patients revealed an autosomal dominant late-onset presentation of RP associated with progressive, bilateral sensorineural hearing loss that occurred in the second to third decades of life with no vestibular involvement. Panel-based genetic testing revealed a heterozygous c.1168C>T, p.Arg390Trp variant in the beta-tubulin 4B gene (TUBB4B) only in affected family members. Based on in silico analysis, segregation analysis through the family, and literature evaluation, this variant is likely to be the disease-causing variant inherited in an autosomal dominant manner. We searched our local database of ~1,000 patients with IRD, and no other TUBB4B variants were identified, confirming this is a rare disease variant. Knockdown of tubb4b in zebrafish revealed cone and rod photoreceptor abnormalities in the retina and hydrocephalus in the developing brain, resulting in early larval lethality. Conclusions: For the first time, we describe a multigenerational family with a TUBB4B gene variant p.(Arg390Trp) segregating with deaf-blindness, establishing autosomal dominant inheritance. This further confirms that the Arg390 codon is a mutation hotspot. We also expand the range of phenotypes seen with the p.(Arg390Trp) TUBB4B gene variant to include typical RP as well as a milder, pericentral RP. Furthermore, our studies suggest there is conservation of TUBB4B ciliary function between zebrafish and humans, making zebrafish a better model system for studying vision loss than the mouse model.


  • Open Access

    RPE65 variant p.(E519K) causes a novel dominant adult-onset maculopathy in 83 affected individuals

    by Eline Van Vooren, Filip Van Den Broeck, Quinten Mahieu, Eline Geens, Mattias Van Heetvelde, Marieke De Bruyne, Stijn Van de Sompele, Sheetal Uppal, Eugenia Poliakov, Claire-Marie Dhaenens, et al.

    Recessive RPE65-related retinopathy is an inherited retinal disease (IRD) that is a well-established target for gene therapy. Dominant RPE65-related retinopathy, however, due to Irish founder variant p.(D477G), is extremely rare. Here, we report the discovery, replication and characterization of a novel dominant retinopathy caused by RPE65 variant p.(E519K), identified in 83 individuals of European ancestry across IRD registries (Belgian discovery cohort, n=2,873; replication cohort, n=18,796). Long-read sequencing-based haplotyping revealed a shared region of 464 kb, supporting a founder effect. Genotype-phenotype data support dominant inheritance and phenotypic variability respectively, characterized by late-onset macular dystrophy with two main subtypes, a pathognomonic mottled subtype and a pattern dystrophy subtype. Functional studies showed that the p.(E519K) variant affects RPE65 enzymatic activity, correlating with lower protein expression. Protein modelling and cellular thermal shift assays further supported a destabilizing effect on protein structure. Overall, our work provides strong genetic, clinical, molecular and functional evidence for a novel dominant RPE65 retinopathy in multiple families in Europe and North America due to a Belgian founder variant. This discovery reduces the diagnostic gap in dominant IRD, particularly in individuals of European ancestry. Finally, it lays the foundation for developing therapeutic strategies targeting dominant RPE65 retinopathy.


  • Novel Variants in ABCA4-Related Retinopathies with Structural Re-Assessment of Variants of Uncertain Significance

    by Kevin Gregory-Evans, Olubayo U. Kolawole, Robert S. Molday, Cheryl Y. Gregory-Evans

    Introduction: Conclusive molecular genetic diagnoses in inherited retinal diseases remains a major challenge due to the large number of variants of uncertain significance (VUS) identified in genetic testing. Here, we determined the genotypic and phenotypic spectrum of ABCA4 gene variants in a cohort of Canadian inherited retinal dystrophy subjects. Methods: This retrospective study evaluated 64 subjects with an inherited retinal dystrophy diagnosis with variants in the ABCA4 gene. Pathogenicity of variants was assessed by comparison to genetic databases and in silico modelling. ABCA4 variants classified as VUS were further evaluated using a cryo-electron structural model of the ABCA4 protein to predict impact on protein function and were also assessed for evolutionary conservation. Results: Conclusive disease-causing biallelic ABCA4 variants were detected in 52 subjects with either Stargardt’s disease, cone-rod dystrophy, macular dystrophy, or pattern dystrophy. A further 14 variants were novel comprising 1 nonsense, 1 frameshift, 3 splicing, and 9 missense variants. Based on in silico modelling, protein modelling and evolutionary conservation from human to zebrafish, we re-classified 5 of these as pathogenic and a further 3 as likely pathogenic. We also added to the ABCA4 phenotypic spectrum seen with four known pathogenic variants (c.2161-2A>G; Leu296Cysfs*4; Arg1640Gln; and Pro1380Leu). Conclusions: This study expands the genotypic and phenotypic spectrum of ABCA4 disease-associated variants. By panel-based genetic testing, we identified 14 novel ABCA4 variants of which 8 were determined to be disease-causing or likely disease-causing. These methodologies could circumvent somewhat the need for labour intensive in vitro and in vivo assessments of novel ABCA4 variants.


  • Photoreceptor precursor cell integration into rodent retina after treatment with novel glycopeptide PKX‐001

    by Ishaq A. Viringipurampeer, Anat Yanai, Vahitha S. Nizamudheen, Cheryl Y. Gregory‐Evans, Kevin Gregory‐Evans

    Cell replacement therapy is emerging as an important approach in novel treatments for neurodegenerative diseases. Many problems remain, in particular improvements are needed in the survival of transplanted cells and increasing functional integration into host tissue. These problems arise because of immune rejection, suboptimal precursor cell type, trauma during cell transplantation, toxic compounds released by dying tissues and nutritional deficiencies. We recently developed an ex vivo system to facilitate identification of factors contributing to the death of transplanted neuronal (photoreceptor) and showed 2.8‐fold improvement in transplant cell survival after pre‐treatment with a novel glycopeptide (PKX‐001). In this study we extended these studies to look at cell survival, maturation and functional integration in an in vivo rat model of rhodopsin‐mutant retinitis pigmentosa causing blindness. We found that only when human photoreceptor precursor cells (PPCs) were pre‐incubated with PKX‐001 prior to transplantation, did the cells integrate and mature into cone photoreceptors expressing S‐opsin or L/M opsin. In addition, ribbon synapses were observed in the transplanted cells suggesting they were making synaptic connections with the host tissue. Furthermore, optokinetic tracking and electroretinography responses in vivo were significantly improved compared to cell transplants without PKX‐001 pre‐treatment. These data demonstrate that PKX‐001 promotes significant long‐term stem cell survival in vivo, providing a platform for further investigation towards the clinical application to repair damaged or diseased retina.


  • Open Access

    Photoreceptor precursor cell integration into rodent retina after treatment with novel glycopeptide PKX-001

    by Ishaq A. Viringipurampeer, Anat Yanai, Cheryl Y. Gregory-Evans, Kevin Gregory-Evans

    SUMMARY: Cell replacement therapy is emerging as an important approach in novel treatments for neurodegenerative diseases. Many problems remain, in particular improvements are needed in the survival of transplanted cells and increasing functional integration into host tissue. These problems arise because of immune rejection, suboptimal precursor cell type, trauma during cell transplantation, toxic compounds released by dying tissues and nutritional deficiencies. We recently developed an ex vivo system to facilitate identification of factors contributing to the death of transplanted neuronal (photoreceptor) and showed 2.8-fold improvement in transplant cell survival after pre-treatment with a novel glycopeptide (PKC-100). In this study we extended these studies to look at cell survival, maturation and functional integration in an in vivo rat model of rhodopsin-mutant retinitis pigmentosa causing blindness. We found that only when human photoreceptor precursor cells (PPCs) were pre-incubated with PKX-100 prior to transplantation, did the cells integrate and mature into cone photoreceptors expressing S-opsin or L/M opsin. In addition, ribbon synapses were observed in the transplanted cells suggesting they were making synaptic connections with the host tissue. Furthermore, optokinetic tracking and electroretinography responses in vivo were significantly improved compared to cell transplants without PKX-100 pre-treatment. These data demonstrate that PKX-100 promotes significant long-term stem cell survival in vivo , providing a platform for further investigation towards the clinical application to repair damaged or diseased retina.


  • Open Access

    Linkage analysis identifies an isolated strabismus locus at 14q12 overlapping with FOXG1 syndrome region

    by Xin (Cynthia) Ye, Nicole M. Roslin, Andrew D. Paterson, Care4Rare Canada, Christopher Lyons, Victor Pegado, Phillip Richmond, Casper Shyr, Oriol Fornes, Xiaohua Han, et al.

    Strabismus is a common condition, affecting 1-4% of individuals. Isolated strabismus has been studied in families with Mendelian inheritance patterns. Despite the identification of multiple loci via linkage analyses, no specific genes have been identified from these studies. The current study is based on a seven-generation family with isolated strabismus inherited in an autosomal dominant manner. A total of 13 individuals from a common ancestor have been included for linkage analysis, and a single linkage signal has been identified at chromosome 14q12 with a multipoint LOD score of 4.69. Disruption of this locus is known to cause FOXG1 syndrome (or congenital Rett syndrome; OMIM #613454 and *164874), in which 84% of affected individuals present with strabismus. With the incorporation of next generation sequencing and in-depth bioinformatic analyses, a 4bp non-coding deletion was prioritized as the top candidate for the observed strabismus phenotype. The deletion is predicted to disrupt regulation of FOXG1 , which encodes a transcription factor of the Forkhead family. Suggestive of an auto-regulation effect, the disrupted sequence matches the consensus FOXG1 and Forkhead family transcription factor binding site and has been observed in previous ChIP-seq studies to be bound by Foxg1 in early mouse brain development. The findings of this study indicate that the strabismus phenotype commonly observed within FOXG1 syndrome is separable from the more severe syndromic characteristics. Future study of this specific deletion may shed light on the regulation of FOXG1 expression and may enhance our understanding of the mechanisms contributing to strabismus and FOXG1 syndrome. Author summary: Eye misalignment, or strabismus, can affect up to 4% of individuals. When strabismus is detected early, intervention in young children based on eye patching and/or corrective lenses can be beneficial. In some cases, corrective surgeries are used to align the eyes, with many individuals requiring multiple surgeries over a lifetime. A better understanding of the causes of strabismus may lead to earlier detection as well as improved treatment options. Hippocrates observed that strabismus runs in families over 2,400 years ago, an early recognition of what we now recognize as a portion of cases arising from genetic causes. We describe a large family affected by strabismus and identify a single region on chromosome 14 that may be responsible. The region contains FOXG1 , in which mutations are known to cause a severe syndrome, with 84% of affected individuals also having strabismus. We identify a 4bp deletion in the region that appears to auto-regulate when FOXG1 is active. Future study of this genetic alteration may enhance our understanding of the mechanisms of strabismus.